The Devyser blog

Devyser a leading provider of genetic testing solutions, has been awarded a significant tender for...

Devyser has launched Devyser Thalassemia v2, a next-generation sequencing (NGS) solution designed...

Thalassemia and hemoglobinopathies are among the most common genetic disorders worldwide, affecting...

Hereditary cancers, particularly breast and ovarian cancers, pose a significant risk for many...